White Papers

Title Author Date Avoiding No Man's Land: Potential Unintended Consequences of Follow-On Biologics Deloitte 01/05/2010   Best Practices in Demand and Inventory Planning CDC Software 02/09/2009   SAP Support of the Healthcare Supply Chain’s Ongoing Effort to Ensure Patient Safety and Drive Business Value SAP 12/05/2008   Residual Solvents by HT3 Headspace in Reference to USP 467 with a Comparison of Static Versus Dynamic Headspace Analysis Teledyne Tekmar 09/22/2008   Nanoparticles in Pharmaceutical Manufacturing NETZSCH Fine Particle Technology, LLC 04/14/2008   The Impact of Nanotechnology in Drug Delivery: Global Developments, Market Analysis, and Future Prospects NanoMarkets, LC 11/01/2007   RABS: Injecting Change into Syringe Drug Delivery Joerg Zimmermann, head of production, Vetter Pharma 08/14/2006   Phase Transformation in Solid Pharmaceutical Materials Denny Mahlin, Uppsala Faculty of Pharmacy 02/20/2006   CDER's 2004 Report to the Nation: Improving Public Health Through Human Drugs FDA's Center for Drug Evaluation and Research 08/23/2005   Pharma 2010: The Threshold of Innovation IBM Business Consulting Services 10/19/2004   Search Result: 1 - 10 of 10